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Guided transport of biologically active molecules (most of them toxic and with systemic side 
effects) to target specific sites in human body has been a focus of research in therapeutics in 
the past years. Magnetoliposomes (liposomes entrapping magnetic nanoparticles) are of large 
importance, as they can overcome many pharmacokinetics problems and can be guided and 
localized to the therapeutic site of interest by external magnetic field gradients [1,2]. In this 
work, nickel ferrite nanoparticles (NPs) with size distribution of 11±5 nm were obtained. 
Synthesized NPs show superparamagnetic behaviour at room temperature (magnetic 
squareness of 7.2×10-5 and coercivity field of 12 Oe), being suitable for biological applications. 
These NPs were either entrapped in liposomes, originating aqueous magnetoliposomes 
(AMLs), or covered with a lipid bilayer, forming dry magnetoliposomes (DMLs), the last ones 
prepared by a new promising route. Recently, AMLs and DMLs containing nickel-based 
nanoparticles were successfully prepared and characterized [3]. A potential antitumor 
compound [4] was successfully incorporated into the lipid bilayer of magnetoliposomes. DMLs 
structure was evaluated by FRET (Förster Resonance Energy Transfer) measurements 
between the fluorescent-labeled lipids NBD-C12-HPC (donor) included in the second lipid layer 
and rhodamine B DOPE (acceptor) in the first lipid layer. A FRET efficiency of 23% was 
calculated, with a corresponding donor-acceptor distance (r) of 3.11 nm, confirming DMLs 
structure. Preliminary assays of the non-specific interactions of both types of magnetoliposomes 
with biological membranes (modeled by giant unilamellar vesicles, GUVs) were performed, 
keeping in mind future applications of drug delivery using this type of magnetic systems. 
Membrane fusion between magnetoliposomes and GUVs was confirmed by FRET.  
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Figure 1 - A. Fluorescence spectra (exc=470 nm) of DMLs labeled with NBD-C12-HPC and Rhodamine 
B-DOPE, before and after interaction with GUVs. B: Illustration of the fusion between the GUVs and 
DMLs labeled with both NBD-C12-HPC and Rhodamine B-DOPE. 
